Liver aetiological screen – ICST

Liver aetiological screen

Tutorial presented by Dr Andrew Yeoman, National Liver Clinical Lead and Consultant Hepatologist, Aneurin Bevan University Health Board

A Liver Aetiological Screen investigates the cause for underlying liver disease, including:

  • Viral hepatitis (if the blood test abnormality is chronic this should include hepatitis b and c, if the blood test abnormality is acute this should include hepatitis a and e)
  • Autoimmune liver disease (measurements of AMA, SMA and ANA, as well as serum immunoglobulins)
  • Haemochromatosis (measurement of serum ferritin and transferrin saturation)
  • Alpha-1 antitrypsin deficiency (measurement of alpha-1 antitrypsin)
  • Wilson’s disease (measurement of caeruloplasmin)

 

A liver ultrasound scan, while not part of a liver aetiological screen, should be performed at this stage as an important part of the diagnostic work-up to look for features of advanced liver disease such as splenomegaly.

Liver aetiological screen

Tutorial presented by Dr Andrew Yeoman, National Liver Clinical Lead and Consultant Hepatologist, Aneurin Bevan University Health Board

A Liver Aetiological Screen investigates the cause for underlying liver disease, including:

  • Viral hepatitis (if the blood test abnormality is chronic this should include hepatitis b and c, if the blood test abnormality is acute this should include hepatitis a and e)
  • Autoimmune liver disease (measurements of AMA, SMA and ANA, as well as serum immunoglobulins)
  • Haemochromatosis (measurement of serum ferritin and transferrin saturation)
  • Alpha-1 antitrypsin deficiency (measurement of alpha-1 antitrypsin)
  • Wilson’s disease (measurement of caeruloplasmin)

 

A liver ultrasound scan, while not part of a liver aetiological screen, should be performed at this stage as an important part of the diagnostic work-up to look for features of advanced liver disease such as splenomegaly.

Mark as Understood

More like this

Conditions that lead to abnormal liver blood tests

Hepatitic or Cholestatic?

Performing a fibrosis risk assessment in practice

© Institute of Clinical Science and Technology (ICST) 2020 Support: support@icst.org.uk